Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens
This piece has moved to our Academic Articles Section, find the full text here: ‘Tuberculosis drug regimens and their efficacies‘
Contributor Details
Andrew
Nunn
Professor of Epidemiology
Medical Research Council Clinical Trials Unit at UCL
Phone: +44 (0)207 670 4703
a.nunn@ucl.ac.uk
https://www.mrcctu.ucl.ac.uk/Editor's Recommended Articles
-
Must Read >> Treating multi-drug resistant tuberculosis -
Must Read >> Tuberculosis prevention efforts in Africa -
Must Read >> Tackling tuberculosis (TB) in Africa -
-
Must Read >> The global picture of Tuberculosis: A view from WHO
